Xarelto Lawsuit

The blood thinner Xarelto® is linked to uncontrolled bleeding.

Approved in 2011, Xarelto® is a new type of blood thinner manufactured by Bayer and marketed in the United States by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. It is once-daily pill for atrial fibrillation, a condition that affects about 3 million people in the United States. Xarelto® is prescribed to prevent blood clots that can obstruct the blood flow to vital organs.

The blood thinner Xarelto® is linked to uncontrolled bleeding.

Xarelto® Side Effects

Side effects associated with Xarelto include:
Intestinal Bleeding
Brain Hemorrhaging
Internal Bleeding
Heart Attack
Gastrointestinal Bleeding
Blood Clots

When bleeding occurs near a major organ, blood flow to that organ is interrupted, causing it to lose some or all of its functionality. Pools of blood may form within the body that can cause other dangerous health risks, and because Xarelto® prevents clotting, bleeding will continue until the drug is out of the system.

Xarelto® is considered a high-risk prescription drug because it can cause excessive internal bleeding among other injuries in patients. While all blood thinners have the risk of internal bleeding, older drugs have emergency antidotes to prevent serious injury. Xarelto® does not have an antidote.

The content on this web page is for informational purposes only.


For a FREE, no-obligation case evaluation, call now at 877-539-1539 or complete our form.

Your name:
Your contact information
Best time to reach you:

*By submitting this form, I am granting permission to be contacted via phone, email, text or any other means. I am also confirming that I understand that no attorney-client relationship exists without a specific written retainer agreement between myself and a law firm.